AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization: AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
Tax period: 2011-01-01 to 2011-12-31
Filed: 2012-11-01
IRS object ID: 201243069349301119
Schema version: 2011v1.2
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2012-11-01T13:15:27-05:00	Timestamp
Tax Period End Date	2011-12-31	TaxPeriodEndDate

Preparer Firm PreparerFirm

Field	Value	IRS element (for citing)
EIN	521855942	EIN

Preparer Firm Business Name PreparerFirmBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	TATE AND TRYON	BusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

Field	Value	IRS element (for citing)
Address Line1	2021 L STREET NW SUITE 400	AddressLine1
City	WASHINGTON	City
State	DC	State
ZIP Code	20036	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnType
Tax Period Begin Date	2011-01-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	136180380	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Control	AMER	NameControl
Phone	5714831300	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD NO 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	PAUL AINES	Name
Title	CPA, CFO	Title
Phone	5714831300	Phone
Date Signed	2012-11-01	DateSigned
Authorize Third Party	1	AuthorizeThirdParty

Preparer Preparer

Field	Value	IRS element (for citing)
Name	DEBORAH G KOSNETT	Name
PTIN	P00290720	PTIN
Phone	2022932200	Phone

Field	Value	IRS element (for citing)
Tax Year	2011	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Doing Business As DoingBusinessAs

Field	Value	IRS element (for citing)
Business Name Line1	ASCO	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	ALLEN LICHTER MD	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD NO 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	139032590	GrossReceipts
Group Return For Affiliates	0	GroupReturnForAffiliates
Organization501c3	X	Organization501c3
Web Site	WWW.ASCO.ORG	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1964	YearFormation
State Legal Domicile	NY	StateLegalDomicile
Activity Or Mission Description	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, PREVENTION AND DELIVERY OF HIGH QUALITY PATIENT CARE.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	18	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	17	NbrIndependentVotingMembers
Total Nbr Employees	303	TotalNbrEmployees
Total Nbr Volunteers	1200	TotalNbrVolunteers
Total Gross UBI	10576109	TotalGrossUBI
Net Unrelated Business Txbl Income	2108381	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	8931139	ContributionsGrantsPriorYear
Contributions Grants Current Year	7731584	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	70399472	ProgramServiceRevenuePriorYear
Program Service Revenue CY	72435660	ProgramServiceRevenueCY
Investment Income Prior Year	761935	InvestmentIncomePriorYear
Investment Income Current Year	2649887	InvestmentIncomeCurrentYear
Other Revenue Prior Year	-537553	OtherRevenuePriorYear
Other Revenue Current Year	327026	OtherRevenueCurrentYear
Total Revenue Prior Year	79554993	TotalRevenuePriorYear
Total Revenue Current Year	83144157	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	1766751	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	1923073	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	26424110	SalariesEtcPriorYear
Salaries Etc Current Year	26305710	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	193150	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	520215	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	4735797	TotalFundrsngExpCurrentYear
Other Expense Prior Year	41452554	OtherExpensePriorYear
Other Expenses Current Year	43619831	OtherExpensesCurrentYear
Total Expenses Prior Year	69836565	TotalExpensesPriorYear
Total Expenses Current Year	72368829	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	9718428	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	10775328	RevenuesLessExpensesCY
Total Assets BOY	157835906	TotalAssetsBOY
Total Assets EOY	162402498	TotalAssetsEOY
Total Liabilities BOY	93957853	TotalLiabilitiesBOY
Total Liabilities EOY	103704424	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	63878053	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	58698074	NetAssetsOrFundBalancesEOY
Info In Schedule O Part III	X	InfoInScheduleOPartIII
Mission Description	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, PREVENTION AND DELIVERY OF HIGH QUALITY CARE.ASCO VISION STATEMENTS:-- ALL CANCER PATIENTS WILL HAVE LIFELONG ACCESS TO HIGH QUALITY, EFFECTIVE, AFFORDABLE AND COMPASSIONATE CARE.-- THE MOST ACCURATE CANCER INFORMATION WILL BE AVAILABLE SO THAT PATIENTS AND PHYSICIANS CAN MAKE INFORMED DECISIONS ABOUT CANCER PREVENTION AND TREATMENT.-- INFORMATION WE LEARN FROM EVERY PATIENT WILL BE USED TO ACCELERATE PROGRESS AGAINST CANCER.-- RESOURCES WILL EXIST TO ATTRACT THE BEST CLINICIANS AND INVESTIGATORS TO PROVIDE OPTIMAL PATIENT CARE AND TO CONDUCT TRANSFORMATIVE RESEARCH. --ASCO WILL BE RECOGNIZED AS THE MOST TRUSTED SOURCE OF CANCER INFORMATION WORLDWIDE.	MissionDescription
Significant New Program Services	0	SignificantNewProgramServices
Significant Change	0	SignificantChange
Expense	28457856	Expense
Grants	1239672	Grants
Revenue	44349572	Revenue
Description	EDUCATIONAL AND SCIENTIFIC MEETINGS AND PRODUCTS AND PROFESSIONAL DEVELOPMENT: ASCO PROVIDES EDUCATIONAL AND SCIENTIFIC PROGRAMS AND CONTENT ON A WIDE VARIETY OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF DIFFERENT FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS LIVE MEETINGS ON CUTTING EDGE RESEARCH AND SCIENCE IN THE FIELD OF CLINICAL ONCOLOGY. THE SCIENTIFIC RESEARCH AND EDUCATION PRESENTED AT THE MEETINGS ENHANCE KNOWLEDGE ABOUT CANCER, THUS ADVANCING HIGH-QUALITY CANCER CARE.THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER EDUCATIONAL AND SCIENTIFIC MEETING IN THE ONCOLOGY COMMUNITY AND THE THEMATIC MEETINGS PRESENTED OR CO-SPONSORED BY ASCO PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC PROGRAMMING ON SPECIFIC TYPES OF CANCERS. ASCO'S EDUCATIONAL AND SCIENTIFIC PROGRAMS SERVE THE DIVERSE NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE AND THROUGH THE CONTINUUM OF THEIR CAREERS. APPROPRIATE PROGRAMS ARE PROVIDED FOR ONCOLOGY FELLOWS, JUNIOR FACULTY MEMBERS, ONCOLOGY PROGRAM DIRECTORS, AND OTHERS TO MEET THE CHANGING NEEDS OF PEOPLE LIVING WITH CANCER AND ADDRESS THE MODERN-DAY PRACTICE OF ONCOLOGY. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS, IMPLEMENTS AND EVALUATES CONTINUING MEDICAL EDUCATION (CME) TO SUPPORT THE CONTINUED EDUCATION OF ONCOLOGISTS SO THAT THEY ARE BETTER PREPARED TO MEET THE PREVENTION, DIAGNOSIS AND TREATMENT NEEDS OF THEIR PATIENTS. CURRENTLY, ASCO HOLDS THE STATUS OF ACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION COUNCIL FOR CME FOR ASCO'S CME PROGRAM.ASCO MAKES MUCH OF THE CONTENT FROM ITS MEETINGS AND OTHER EDUCATIONAL AND SCIENTIFIC CONTENT AVAILABLE TO THE GENERAL PUBLIC THROUGH TWO ASCO WEBSITES: WWW.ASCO.ORG AND WWW.CANCER.NET. ADDITIONALLY, ASCO MAKES EDUCATIONAL AND SCIENTIFIC MATERIALS AVAILABLE THROUGH A VARIETY OF CHANNELS, INCLUDING BOOKS, DVDS, VIRTUAL MEETINGS, PODCASTS AND PUBLIC FORUMS. HIGHLIGHTS OF THE 2011 ACTIVITIES INCLUDE: APPROXIMATELY 32,000 PEOPLE ATTENDED THE 2011 ASCO ANNUAL MEETING, INCLUDING PHYSICIANS, NURSES, CAREGIVERS, PATIENTS, AND PATIENT ADVOCATES. MORE THAN HALF OF ATTENDEES AT THE 2011 ASCO ANNUAL MEETING WERE INTERNATIONAL ATTENDEES. THE 2011 ANNUAL MEETING FEATURED OVER 250 EDUCATIONAL AND SCIENTIFIC SESSIONS AND NEARLY 5,000 ABSTRACTS WERE PRESENTED OR PUBLISHED. OVER 2,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY.-- IN 2011, ASCO WAS THE LEAD SPONSOR OF SEVERAL THEMATIC SYMPOSIA FOCUSING ON GENITOURINARY CANCERS, GASTROINTESTINAL CANCERS, BREAST CANCER, AND HEALTH INFORMATION TECHNOLOGY, COLLECTIVELY DRAWING OVER 6,000 ATTENDEES. THESE THEMATIC SYMPOSIA WERE OPEN TO THE GENERAL PUBLIC. -- IN 2011, ASCO SPONSORED OR CO-SPONSORED OVER 30 EDUCATIONAL AND SCIENTIFIC SYMPOSIA, WORKSHOPS, AND COURSES OUTSIDE THE UNITED STATES ON A WIDE VARIETY OF CANCER-RELATED TOPICS TO IMPROVE ONCOLOGY CARE IN (AND) AROUND THE WORLD. THESE MEETINGS INCLUDE: -- ANNUAL MEETING -- GI SYMPOSIUM -- GU SYMPOSIUM -- BREAST CANCER SYMPOSIUM -- HEALTH INFORMATION TECHNOLOGY -- BEST OF ASCO SEATTLE -- BEST OF ASCO MIAMI -- ASCO/AACR METHODS WORKSHOPINTERNATIONAL AFFAIRS MEETINGS AND COURSES -- BEST OF ASCO INTERNATIONAL (19) -- JOINT SYMPOSIA (12) -- ADVANCED CANCER COURSES (5)ASCO PUBLISHES ASCO DAILY NEWS PRODUCTS FOR EACH OF ITS MAJOR LIVE MEETINGS. THE DAILY NEWS PRODUCTS INCLUDE PRINT NEWSPAPERS THAT ARE DISTRIBUTED ONSITE TO ALL ATTENDEES AT THE LIVE EVENT AND ONLINE (THE ENTIRETY OF THE PRINT VERSIONS PLUS BONUS COVERAGE) TO ASCO MEMBERS AND TO THE GENERAL PUBLIC. THE DAILY NEWS PRODUCTS INCLUDE COVERAGE OF KEY EDUCATIONAL AND SCIENTIFIC SESSIONS, EDITORIALS BY EXPERTS IN VARIOUS SUBSPECIALTIES, INFORMATION ABOUT ASCO PRODUCTS AND RESOURCES, PROFILES OF GRANT AND AWARD WINNERS, AND COMMENTARY AND TOPICS OF INTEREST TO INTERNATIONAL ATTENDEES AND MEMBERS.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	10970608	Expense
Grants	50000	Grants
Revenue	23954819	Revenue
Description	EDUCATIONAL PUBLICATIONS: ASCO PUBLISHES TWO EDUCATIONAL JOURNALS ADDRESSING CLINICAL ONCOLOGY THAT ARE AVAILABLE TO THE PUBLIC. JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED, PEER-REVIEWED JOURNAL THAT DISSEMINATES QUALITY ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. JCO INCLUDES ORIGINAL REPORTS, SELECTED EDITORIALS, COMMENTARIES, REVIEWS, AND OTHER WORK THAT RELATE TO THE CARE OF PATIENTS WITH CANCER. JCO IS TRANSLATED INTO A NUMBER OF LANGUAGES IN INTERNATIONAL EDITIONS, THEREBY INCREASING ITS USE INTERNATIONALLY.JOURNAL OF ONCOLOGY PRACTICE (JOP) INCLUDES ORIGINAL RESEARCH, FEATURE ARTICLES, AND COLUMNS ON CLINICAL AND ADMINISTRATIVE MANAGEMENT FOR PRACTICING ONCOLOGISTS, WHICH ARE EDITED BY ONCOLOGISTS.IN 2011, THE JOURNAL OF CLINICAL ONCOLOGY HAD 24,100 ANNUAL SUBSCRIBERS. ADDITIONALLY, THE JCO IMPACT FACTOR INCREASED FOR A FIFTH CONSECUTIVE YEAR, AS REPORTED BY THOMSON REUTERS IN ITS 2010 JOURNAL CITATION REPORT. THE RISE IN THE IMPACT FACTOR OF NEARLY 50% SINCE 2005 IS A REFLECTION OF THE VALUE RESEARCHERS FIND IN JCO CONTENT.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	7216907	Expense
Grants	219815	Grants
Revenue	37230	Revenue
Description	CANCER POLICY AND CLINICAL AFFAIRS: ASCO'S CANCER POLICY AND CLINICAL AFFAIRS DEPARTMENT ADDRESSES POLICY ISSUES RELATING TO CANCER RESEARCH, CARE AND PREVENTION. THE DEPARTMENT WORKS WITH VOLUNTEER COMMITTEES AND ASCO LEADERS TO SHAPE POLICY, LAW AND REGULATION ON ISSUES OF IMPORTANCE TO ONCOLOGY. THE DEPARTMENT'S PROGRAMS COVER A BROAD SPECTRUM OF ISSUES, INCLUDING PATIENT-ORIENTED RESEARCH, HEALTH INSURANCE, CLINICAL PRACTICE, EVIDENCE-BASED GUIDELINES AND TECHNOLOGY ASSESSMENTS, QUALITY ASSESSMENT/IMPROVEMENT, WORKFORCE, DISPARITIES, COST/ACCESS, CANCER SURVIVORSHIP, AND CANCER PREVENTION AND CONTROL. ACTIVITIES INCLUDE HOTLINES, TOOLS AND LEGAL ANALYSIS, EDUCATIONAL WORKSHOPS AND MATERIALS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, ADVOCACY, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY.CANCER POLICY AND CLINICAL AFFAIRS STAFF INTERACT AND COLLABORATE ON A REGULAR BASIS WITH ASCO STATE AND REGIONAL AFFILIATES, OTHER MEDICAL SPECIALTY AND PROFESSIONAL SOCIETIES, CONGRESS, THE ADMINISTRATION, AND PATIENT ADVOCATE ORGANIZATIONS TO ADVANCE COMMON GOALS RELATED TO CANCER RESEARCH AND QUALITY CARE. IN 2011, ASCO'S ACTIVITIES INCLUDED EFFORTS IN THE FOLLOWING AREAS:ADVANCED CANCER- ASCO PUBLISHED A POSITION PAPER ON COMMUNICATION AND DECISION MAKING FOR PATIENTS WITH ADVANCED CANCER. THE PAPER OUTLINES THE GOALS FOR INDIVIDUALIZED CARE, BARRIERS THAT CURRENTLY LIMIT REALIZATION OF THIS VISION, AND POSSIBLE STRATEGIES TO OVERCOME THESE BARRIERS THAT CAN IMPROVE CARE CONSISTENT WITH THE WISHES OF PATIENTS AND EVIDENCE-BASED MEDICINE.CANCER CARE DISPARITIES- TO HELP ADDRESS SERIOUS RACIAL AND ECONOMIC DISPARITIES IN CANCER PREVENTION, DIAGNOSIS, AND TREATMENT IN THE UNITED STATES, ASCO PUBLISHED A POLICY STATEMENT OUTLINING SPECIFIC PROVISIONS OF 2010 PATIENT PROTECTION AND AFFORDABLE CARE ACT THAT HAVE THE POTENTIAL TO REDUCE THESE DISPARITIES. ASCO'S STATEMENT MAKES RECOMMENDATIONS TO ENSURE THAT SUCH PROVISIONS ARE CARRIED OUT EFFECTIVELY, AND URGES ADDITIONAL STEPS TO ADDRESS SYSTEMIC ISSUES INCLUDING INSURANCE REFORM, QUALITY OF CARE, PREVENTION, RESEARCH, AND DIVERSITY IN THE HEALTH CARE WORKFORCE.THE STATE/REGIONAL AFFILIATE PROGRAM- THE AFFILIATE PROGRAM WAS CREATED IN 1993 TO ADDRESS ISSUES RELATING TO THE PRACTICE OF ONCOLOGY, AND TO FACILITATE ASCO'S OWN ADVOCACY PROGRAMS. THE 48 STATE/REGIONAL AFFILIATES INTERACT WITH ASCO THROUGH THE STATE AFFILIATE COUNCIL, WHERE EACH SOCIETY HAS A VOTING REPRESENTATIVE CHARGED WITH SERVING AS THE BRIDGE BETWEEN THE SOCIETY AND ASCO. AFFILIATES HAVE ACCESS TO A NUMBER OF PROGRAMS INCLUDING STATE SOCIETY MEMBERSHIP RECRUITMENT AND RETENTION ASSISTANCE, LEADERSHIP TRAINING, FEDERAL-LEVEL ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL.FEDERAL POLICIES IMPACTING CANCER CARE AND RESEARCH- ASCO REVIEWS AND FREQUENTLY COMMENTS ON POLICIES ISSUED BY FEDERAL AGENCIES, INCLUDING THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS), FOOD AND DRUG ADMINISTRATION (FDA), AND NATIONAL INSTITUTES OF HEALTH. STAFF AND VOLUNTEERS ALSO ACTIVELY PARTICIPATE IN AMERICAN MEDICAL ASSOCIATION (AMA) PROCESSES FOR DEVELOPMENT OF NEW CPT CODES AND VALUATION OF CODES THROUGH THE AMA/SPECIALTY SOCIETY RELATIVE VALUE SCALE UPDATE COMMITTEE (RUC).ORIGINAL DATA COLLECTION- ASCO CONDUCTS STUDIES AND ANALYSES TO ASSESS THE CURRENT STATE OF ONCOLOGY CARE AND RESEARCH AND DETERMINE THE NEED FOR AND IMPACT OF POLICY CHANGES. IN 2011, ASCO COMPLETED THE STUDY OF COLLABORATIVE PRACTICE ARRANGEMENTS FUNDED BY SUSAN G. KOMEN FOR THE CURE(R). THE STUDY DETERMINED THAT COLLABORATIVE PRACTICE TEAMS OF ONCOLOGISTS AND NURSE PRACTITIONERS OR PHYSICIAN ASSISTANTS IMPROVE THE EFFICIENCY OF CANCER CARE AND CONTRIBUTE TO HIGH SATISFACTION RATES FOR PROVIDERS AND PATIENTS.	Description

Activity Other ActivityOther

Field	Value	IRS element (for citing)
Expense	9569928	Expense
Grants	413586	Grants
Revenue	4094039	Revenue
Description	QUALITY: THE ASCO QUALITY DEPARTMENT IS RESPONSIBLE FOR THE DEVELOPMENT OF EVIDENCE-BASED GUIDELINES, DEVELOPING AND VALIDATING QUALITY MEASURES IN ONCOLOGY, QUALITY IMPROVEMENT AND MEASUREMENT. THE DEPARTMENT IS ALSO TASKED WITH THE DEVELOPMENT OF THE FIRST RAPID LEARNING SYSTEM IN ONCOLOGY WHICH IS INTENDED TO TRANSFORM THE WAY ONCOLOGISTS PRACTICE, DO RESEARCH, LEARN, AND INTERACT WITH THEIR PATIENTS. PROGRAMS INCLUDE:QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI)- A QUALITY ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES. QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3)COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. THE PROGRAM IS UNIQUE IN THE CANCER COMMUNITY AND HAS BEEN ACCEPTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE AS A MECHANISM FOR SATISFYING PRACTICE EVALUATION AND IMPROVEMENT REQUIREMENTS FOR MAINTENANCE OF CERTIFICATION. ASCO SUPPORTS A NUMBER OF COLLABORATIVE GROUPS THAT USE QOPI WITHIN THEIR INITIATIVES TO DRIVE THEIR QUALITY IMPROVEMENT EFFORTS. OVER 700 PRACTICES NATIONWIDE, INCLUDING HAWAII, ALASKA, GUAM, AND PUERTO RICO ARE ENROLLED IN THE PROGRAM.QOPI CERTIFICATION PROGRAM- THE QOPI CERTIFICATION PROGRAM BUILDS UPON THE SUCCESS OF QOPI. QOPI CERTIFICATION DEMONSTRATES A COMMITMENT TO EXCELLENCE AND ONGOING QUALITY IMPROVEMENT IN THE HEMATOLOGY-ONCOLOGY OUTPATIENT PRACTICE.THE QOPI CERTIFICATION PROGRAM IS CARRIED OUT BY A LIMITED LIABILITY COMPANY (LLC), THE INSTITUTE OF CLINICAL EXCELLENCE, LLC (ICE). (D/B/A QOPI CERTIFICATION PROGRAM) THE SOLE MEMBER AND MANAGER OF ICE IS ASCO. THE GOALS OF THE QOPI CERTIFICATION PROGRAM ARE TO PROMOTE HIGH QUALITY CANCER CARE, PROVIDE A TRUSTED SOLUTION TO ADDRESS EXTERNAL DEMAND FOR QUALITY ACTIVITIES, AND REDUCE REDUNDANT PROGRAMS OR ADMINISTRATIVE BURDENS RELATED TO DEMONSTRATION OF QUALITY.NEW GUIDELINES AND ONGOING UPDATES- ASCO NOW HAS 27 PUBLISHED PRACTICE GUIDELINES AND 3 PROVISIONAL CLINICAL OPINIONS (PCO'S) ADDRESSING A WIDE RANGE OF CANCER TREATMENT, DIAGNOSIS, AND MANAGEMENT ISSUES. AN ADDITIONAL 4 GUIDELINES AND 1 PCO ARE IN DEVELOPMENT, ALONG WITH 8 UPDATES TO EXISTING GUIDELINES. IN ADDITION, ASCO HAS ENDORSED TWO GUIDELINES DEVELOPED BY OUTSIDE ORGANIZATIONS.MEMBER SERVICES: MEMBER SERVICES WORKS TO SUPPORT ASCO'S MORE THAN 30,000 MEMBERS THROUGH ITS DAILY ACTIVITIES, INCLUDING PROCESSING NEW MEMBERSHIP APPLICATIONS AND MEMBER DUES, PHONE AND E-MAIL COMMUNICATIONS, RESEARCHING AND FULFILLING MEMBER REQUESTS, MAINTAINING THE INTEGRITY OF MEMBER DATA, AND NEW MEMBER RECRUITMENT AND RETENTION EFFORTS.ASCO CONNECTION IS THE OFFICIAL BIMONTHLY MEMBER MAGAZINE FOR AND ABOUT MEMBERS OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY. IT IS THE PRIMARY SOURCE OF INFORMATION ABOUT ASCO'S PROGRAMS AND SERVICES. ALONG WITH ITS COMPANION PROFESSIONAL NETWORKING SITE, ASCOCONNECTION.ORG, ASCO CONNECTION PROMOTES OPPORTUNITIES FOR INTERACTION BETWEEN ASCO AND ITS MEMBERS, AND MEMBERS AND THEIR COLLEAGUES. ASCOCONNECTION.ORG FEATURES BLOGS BY LEADERS IN THE FIELD, DISCUSSION FORUMS, COMMENT-ENABLED ARTICLES, AND OPPORTUNITIES TO CREATE GROUPS.COMMUNICATIONS AND PATIENT INFORMATION: ASCO HAS A FREE PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET), AVAILABLE TO THE PUBLIC, INCLUDING PATIENTS, THEIR CAREGIVERS, FAMILY MEMBERS AND FRIENDS, THE MEDIA AND HEALTH CARE PROFESSIONALS THAT PROVIDES UP-TO-DATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, SURVIVORSHIP, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. THE SITE OFFERS MEDICAL INFORMATION ON MORE THAN 120 TYPES OF CANCER AND RELATED SYNDROMES, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, AND HOW TO COPE WITH THE EMOTIONAL AND SOCIAL EFFECTS OF LIVING WITH CANCER. IN ADDITION TO ITS WEBSITE CONTENT, ASCO OFFERS PRINTED MATERIALS FOR PATIENTS, SUCH AS: CANCER.NET'S GUIDES TO CANCER (DETAILED GUIDES COVERING SYMPTOMS, RISK FACTORS, DIAGNOSIS, STAGING, TREATMENT, CLINICAL TRIAL RESOURCES, SIDE EFFECTS, AFTER TREATMENT, CURRENT RESEARCH AND QUESTIONS TO ASK THE DOCTOR), ASCO ANSWERS FACT SHEETS (A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC, INCLUDING AN OVERVIEW, AN ILLUSTRATION OF WHERE IT STARTS, HOW IT IS TREATED, TERMS TO KNOW, QUESTIONS TO ASK THE DOCTOR, BOOKLETS ON CANCER SURVIVORSHIP, ADVANCED CANCER CARE PLANNING, MANAGING THE COST OF CANCER CARE, AND CANCER IN OLDER ADULTS.ADDITIONAL RESOURCES ARE AVAILABLE ON CANCER.NETFIND AN ONCOLOGIST DATABASE: A FREE SEARCHABLE DATABASE OF ASCO MEMBERS BY SPECIALTY OR LOCATION FOR THOSE IN NEED OF A SPECIALIST.CANCER ADVANCES: SUMMARIES OF RESEARCH ADVANCES IN CLINICAL ONCOLOGY FROM THE JOURNAL OF CLINICAL ONCOLOGY, ASCO'S ANNUAL MEETINGS, AND ASCO SYMPOSIA.WHAT TO KNOW ASCO'S GUIDELINES: PATIENT-FRIENDLY GUIDES BASED ON ASCO'S CLINICAL PRACTICE GUIDELINES FOR PHYSICIANS.RESEARCH AND MEETINGS: INFORMATION ON ASCO'S CLINICAL CANCER ADVANCES REPORT, ASCO'S ANNUAL MEETINGS AND SYMPOSIA, VIRTUAL LECTURES, AND ASCO'S EXPERT PERSPECTIVE ON CANCER NEWS. MULTIMEDIA: MEDICAL ILLUSTRATIONS, VIDEOS, AND PODCASTS ON TOPICS SUCH AS: CANCER RESEARCH, TREATMENT, AND COPING.EXPERT INFORMATION FROM ASCO: ASCO EXPERTS ANSWER QUESTIONS ABOUT CURRENT TOPICS IN CANCER CARE, TREATMENT, AND RESEARCH.CANCER.NET FEATURE ARTICLES: WEEKLY ARTICLES DESIGNED TO PROVIDE IN-DEPTH INFORMATION ON TOPICS OF INTEREST, AS WELL AS PRACTICAL INFORMATION ON CANCER CARE AND TREATMENT.ASCO CANCER TREATMENT SUMMARY FORMS: PRINTABLE FORMS PATIENTS AND THEIR DOCTORS CAN COMPLETE TO HELP KEEP TRACK OF TREATMENT PLANS AND FOLLOW-UP CARE PLANS.CANCER.NET EN ESPANOL: TRANSLATED CONTENT ON THE TREATMENT OF COMMON CANCER TYPES, MANAGING SIDE EFFECTS, AN INTRODUCTION TO CLINICAL TRIALS, AND ASCO'S GUIDELINES. SEVERAL PRINTED PIECES ARE ALSO AVAILABLE IN SPANISH.	Description

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	9569928	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	413586	TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev	4094039	TotalOfOtherProgramServiceRev
Total Program Service Expense	56215299	TotalProgramServiceExpense
Described In501 C3	1	DescribedIn501C3
Schedule B Required	1	ScheduleBRequired
Political Activities	0	PoliticalActivities
Lobbying Activities	1	LobbyingActivities
Subject To Proxy Tax	0	SubjectToProxyTax
Donor Advised Funds	0	DonorAdvisedFunds
Conservation Easements	0	ConservationEasements
Collections Of Art	0	CollectionsOfArt
Credit Counseling	0	CreditCounseling
Term Or Permanent Endowments	0	TermOrPermanentEndowments
Report Land Bldg Equip	1	ReportLandBldgEquip
Report Invest Oth Securities	0	ReportInvestOthSecurities
Report Prog Rel Invest	0	ReportProgRelInvest
Report Other Assets	0	ReportOtherAssets
Report Other Liabilities	1	ReportOtherLiabilities
Report Fin48 Footnote	1	ReportFin48Footnote
Independent Audit Financial Stmt	0	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	1	ConsolidatedAuditFinancialStmt
School	0	School
Foreign Office	0	ForeignOffice
Foreign Activities	1	ForeignActivities
More Than5000 K To Organizations	1	MoreThan5000KToOrganizations
More Than5000 K To Individuals	1	MoreThan5000KToIndividuals
Professional Fundraising	1	ProfessionalFundraising
Fundraising Activities	0	FundraisingActivities
Gaming	0	Gaming
Hospital	0	Hospital
Grants To Organizations	1	GrantsToOrganizations
Grants To Individuals	0	GrantsToIndividuals
Schedule J Required	1	ScheduleJRequired
Tax Exempt Bonds	1	TaxExemptBonds
Invest Tax Exempt Bonds	0	InvestTaxExemptBonds
Escrow Account	0	EscrowAccount
On Behalf Of Issuer	0	OnBehalfOfIssuer
Excess Benefit Transaction	0	ExcessBenefitTransaction
Prior Excess Benefit Transaction	0	PriorExcessBenefitTransaction
Loan To Officer Or DQP	0	LoanToOfficerOrDQP
Grant To Related Person	0	GrantToRelatedPerson
Bsnss Rltnshp With Organization	0	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	0	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	0	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	0	DeductibleNonCashContributions
Deductible Contributions Of Art	0	DeductibleContributionsOfArt
Terminated	0	Terminated
Partial Liquidation	0	PartialLiquidation
Disregarded Entity	1	DisregardedEntity
Related Entity	1	RelatedEntity
Related Org Controlled Entity	1	RelatedOrgControlledEntity
Transaction Related Entity	1	TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org	0	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	0	ActivitiesConductedPartnership
Schedule O Required	1	ScheduleORequired
Number Forms Transmitted With1096	407	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Compliance With Backup Witholding	1	ComplianceWithBackupWitholding
Number Of Employees	303	NumberOfEmployees
Employment Tax Returns Filed	1	EmploymentTaxReturnsFiled
Unrelated Business Income	1	UnrelatedBusinessIncome
Form990-T Filed	1	Form990-TFiled
Foreign Financial Account	0	ForeignFinancialAccount
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTrans
Taxable Party Notification	0	TaxablePartyNotification
Non Deductible Contributions	0	NonDeductibleContributions
Quid Pro Quo Contributions	0	QuidProQuoContributions
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOf
Funds To Pay Premiums	0	FundsToPayPremiums
Premiums Paid	0	PremiumsPaid
Indoor Tanning Services	0	IndoorTanningServices
Info In Schedule O Part VI	X	InfoInScheduleOPartVI
Nbr Voting Governing Body Members	18	NbrVotingGoverningBodyMembers
Number Independent Voting Members	17	NumberIndependentVotingMembers
Family Or Business Relationship	0	FamilyOrBusinessRelationship
Delegation Of Management Duties	0	DelegationOfManagementDuties
Changes To Organizing Docs	1	ChangesToOrganizingDocs
Material Diversion Or Misuse	0	MaterialDiversionOrMisuse
Members Or Stockholders	1	MembersOrStockholders
Election Of Board Members	1	ElectionOfBoardMembers
Decisions Subject To Approval	0	DecisionsSubjectToApproval
Minutes Of Governing Body	1	MinutesOfGoverningBody
Minutes Of Committees	1	MinutesOfCommittees
Officer Mailing Address	0	OfficerMailingAddress
Local Chapters	0	LocalChapters
Form990 Provided To Governing Body	1	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	1	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	1	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	1	RegularMonitoringEnforcement
Whistleblower Policy	1	WhistleblowerPolicy
Document Retention Policy	1	DocumentRetentionPolicy
Compensation Process CEO	1	CompensationProcessCEO
Compensation Process Other	1	CompensationProcessOther
Investment In Joint Venture	0	InvestmentInJointVenture
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
Upon Request	X	UponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	PAUL AINES CPA CFO	BusinessNameLine1

Field	Value	IRS element (for citing)
Telephone Number	5714831300	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (36 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Individual Trustee Or DirectorIndividualTrusteeOrDirector	OfficerOfficer	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation	Key EmployeeKeyEmployee	Highest Compensated EmployeeHighestCompensatedEmployee
MICHAEL LINK MD 10-13
PRESIDENT (11-12)	1.00	X	X	10000	0	0
SANDRA SWAIN MD 08-12
PRESIDENT ELECT (11-12)	1.00	X	X	0	0	0
JAMES ABBRUZZESE MD
BOARD MEMBER (10-13)	1.00	X		0	0	0
EDUARDO CAZAP MD
BOARD MEMBER (09-12)	1.00	X		0	0	0
GARY COHEN MD
BOARD MEMBER (11-14)	1.00	X		0	0	0
SUSAN COHN MD
BOARD MEMBER (09-12)	1.00	X		500	0	0
DANIEL F HAYES MD
BOARD MEMBER (11-14)	1.00	X		0	0	0
MARTIN MURPHY JR PHD DMEDSC
BOARD MEMBER EX OFFICIO	1.00	X		0	0	0
LORI PIERCE MD
BOARD MEMBER (10-14)	1.00	X		0	0	0
CAROLYN RUNOWICZ MD
BOARD MEMBER (11-15)	1.00	X		0	0	0
LYNN SCHUCHTER MD
BOARD MEMBER (09-12)	1.00	X		2250	0	0
FRANCES SHEPHERD MD
BOARD MEMBER (10-14)	1.00	X		500	0	0
GEORGE SLEDGE MD 08-11
IMMED PAST PRES (11-12)	1.00	X		0	0	0
EVERETT VOKES MD
BOARD MEMBER (09-12)	1.00	X		1500	0	0
JULIE VOSE MD
BOARD MEMBER (10-13)	1.00	X		500	0	0
ERIC WINER MD
BOARD MEMBER (11-15)	1.00	X		1000	0	0
PETER YU MD
BOARD MEMBER (09-12)	1.00	X		500	0	0
ROBIN ZON MD FACP
BOARD MEMBER (10-13)	1.00	X		500	0	0
MONICA BERTAGNOLLI MD
BOARD MEMBER (08-11)	1.00	X		0	0	0
BRUCE JOHNSON MD
BOARD MEMBER (08-11)	1.00	X		0	0	0
ROBERT LANGDON MD
BOARD MEMBER (08-11)	1.00	X		0	0	0
ALLEN LICHTER MD
CEO, EX OFFICIO DIRECTOR	37.50	X	X	748894	0	20162
CLIFFORD HUDIS MD 09-12
TREASURER (11-12)	1.00	X	X	25750	0	0
PAUL AINES CPA
CFO	37.50		X	287362	0	32951
DINA MICHELS ESQ
VICE PRES.,GEN COUNSEL,SEC	37.50		X	468167	0	34067
NANCY DALY MSMPH
EXEC DIRECTOR, CCF	37.50			210524	0	23931	X
JEAN COLVARD
S DIR MEMBER & MEETING SVS	37.50			204814	0	18616	X
DEBORAH KAMIN RNPHD
S DIR CANCER POLICY	37.50			285056	0	28788	X
BERNIE KHOO
S DIR INTEGRATED MEDIA	37.50			330928	0	34884	X
CARA MOLINARI
S DIR EDUCATION	37.50			178782	0	12251	X
THERESA VAN SCHAIK
S DIR JOURNALS	37.50			179248	0	22225	X
SUZANNE BRACH
S DIR MARKETING	37.50			194974	0	23504		X
KRISTIN LUDWIG
S DIR COMMUNICATIONS	37.50			221216	0	13690		X
KAY NOLL
S DIR HUMAN RESOURCES	37.50			191726	0	16958		X
DOUGLAS PYLE
S DIR INT'L AFFAIRS	37.50			180714	0	26013		X
ROBERT HAUSER PHARMD PHD
S DIR QUALITY	37.50			166642	0	4410		X

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	3892047	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	0	TotalReportableCompFrmRltdOrgs
Total Other Compensation	312450	TotalOtherCompensation
Number Individuals GT100 K	56	NumberIndividualsGT100K
Formers Listed	0	FormersListed
Total Comp GT150 K	1	TotalCompGT150K
Compensation From Other Sources	0	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation
THE MERZ GROUP
1570 MCDANIEL DR	WEST CHESTER	PA	19380	BRANDING	651939
POLSINELLI SHUGHART PC
1152 15TH STREET NW	WASHINGTON	DC	20005	LEGAL	628385
ASTUTE TECHNOLOGY
11718 BOWMEN GREEN DR	RESTON	VA	20190	VIDEO RECORDING	499353
BECKSTEIN PRODUCTION LLC
12415 ROUSSEAU TERRACE	NORTH POTOMAC	MD	20878	CREATIVE DEVELOPMENT	324996
MCDERMOTT WILL & EMERY LLP
28 STATE STREET	BOSTON	MA	02109	LEGAL	169592

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	10	NumberOfContractorsGT100K
Related Organizations	7731584	RelatedOrganizations
Total Contributions	7731584	TotalContributions

Program Service Revenue ProgramServiceRevenue (5 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome	Unrelated Business RevenueUnrelatedBusinessRevenue
EDUCATION MTGS & PROD	900099	24497991	24497991
PUBLICATIONS	511190	13025746	13025746
MEMBERSHIP	900099	10987041	10987041
ADVERTISING	541800	10929073		10929073
EXHIBITS	900099	9173631	9173631

Total Oth Program Service Revenue TotalOthProgramServiceRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	3822178	TotalRevenueColumn
Related Or Exempt Function Income	3737157	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	85021	UnrelatedBusinessRevenue

Field	Value	IRS element (for citing)
Total Program Service Revenue	72435660	TotalProgramServiceRevenue

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	2029120	TotalRevenueColumn
Exclusion	$2,029,120	ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

Field	Value	IRS element (for citing)
Total Revenue Column	751	TotalRevenueColumn
Exclusion	$751	ExclusionAmount

Royalties Revenue RoyaltiesRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	378423	TotalRevenueColumn
Exclusion	$378,423	ExclusionAmount

Gross Rents GrossRents

Field	Value	IRS element (for citing)
Real	945869	Real

Less Rental Expenses LessRentalExpenses

Field	Value	IRS element (for citing)
Real	1463854	Real

Rental Income Or Loss RentalIncomeOrLoss

Field	Value	IRS element (for citing)
Real	-517985	Real

Net Rental Income Or Loss NetRentalIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	-517985	TotalRevenueColumn
Unrelated Business Revenue	-517985	UnrelatedBusinessRevenue

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	55044595	Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	54393878	Securities
Other	30701	Other

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	650717	Securities
Other	-30701	Other

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	620016	TotalRevenueColumn
Exclusion	$620,016	ExclusionAmount

Other Revenue Misc OtherRevenueMisc (2 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	ExclusionExclusionAmount	Unrelated Business RevenueUnrelatedBusinessRevenue
MAILING LIST	511120	386588	$386,588
OTHER	900099	80000		80000

Field	Value	IRS element (for citing)
Total Other Revenue	466588	TotalOtherRevenue

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	83144157	TotalRevenueColumn
Related Or Exempt Function Income	61421566	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	10576109	UnrelatedBusinessRevenue
Exclusion	$3,414,898	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	1470901	Total
Program Services	1470901	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	452172	Total
Program Services	452172	ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

Field	Value	IRS element (for citing)
Total	4206430	Total
Program Services	2457008	ProgramServices
Management And General	1354870	ManagementAndGeneral
Fundraising	394552	Fundraising

Other Salaries And Wages OtherSalariesAndWages

Field	Value	IRS element (for citing)
Total	17143384	Total
Program Services	11457543	ProgramServices
Management And General	3916864	ManagementAndGeneral
Fundraising	1768977	Fundraising

Pension Plan Contributions PensionPlanContributions

Field	Value	IRS element (for citing)
Total	1394622	Total
Program Services	1078095	ProgramServices
Management And General	212527	ManagementAndGeneral
Fundraising	104000	Fundraising

Other Employee Benefits OtherEmployeeBenefits

Field	Value	IRS element (for citing)
Total	2140029	Total
Program Services	1701697	ProgramServices
Management And General	247216	ManagementAndGeneral
Fundraising	191116	Fundraising

Payroll Taxes PayrollTaxes

Field	Value	IRS element (for citing)
Total	1421245	Total
Program Services	1057068	ProgramServices
Management And General	262283	ManagementAndGeneral
Fundraising	101894	Fundraising

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	507138	Total
Program Services	369909	ProgramServices
Management And General	137229	ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	115860	Total
Management And General	115860	ManagementAndGeneral

Fees For Services Lobbying FeesForServicesLobbying

Field	Value	IRS element (for citing)
Total	148941	Total
Program Services	148941	ProgramServices

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	520215	Total
Fundraising	520215	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	479535	Total
Management And General	479535	ManagementAndGeneral

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	10337950	Total
Program Services	9332324	ProgramServices
Management And General	837991	ManagementAndGeneral
Fundraising	167635	Fundraising

Advertising Advertising

Field	Value	IRS element (for citing)
Total	335665	Total
Program Services	300556	ProgramServices
Management And General	35109	ManagementAndGeneral

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	454066	Total
Program Services	307499	ProgramServices
Management And General	137235	ManagementAndGeneral
Fundraising	9332	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	2135628	Total
Program Services	1247720	ProgramServices
Management And General	887908	ManagementAndGeneral

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	4815933	Total
Program Services	3593801	ProgramServices
Management And General	1222132	ManagementAndGeneral

Travel Travel

Field	Value	IRS element (for citing)
Total	2801507	Total
Program Services	2453269	ProgramServices
Management And General	340304	ManagementAndGeneral
Fundraising	7934	Fundraising

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	7271388	Total
Program Services	6576231	ProgramServices
Management And General	695157	ManagementAndGeneral

Depreciation Depletion DepreciationDepletion

Field	Value	IRS element (for citing)
Total	2435632	Total
Program Services	1768475	ProgramServices
Management And General	608208	ManagementAndGeneral
Fundraising	58949	Fundraising

Insurance Insurance

Field	Value	IRS element (for citing)
Total	389208	Total
Program Services	179183	ProgramServices
Management And General	210025	ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
UBI TAX	440664	1161755	-721091
PRINTING & PRODUCTION	6027583	6023949	3629	5
POSTAGE & SHIPPING	1861587	1841341	20246
DEVELOPMENT FEE TO CONQ	1400000			1400000

All Other Expenses AllOtherExpenses

Field	Value	IRS element (for citing)
Total	1661546	Total
Program Services	1235862	ProgramServices
Management And General	414496	ManagementAndGeneral
Fundraising	11188	Fundraising

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	72368829	Total
Program Services	56215299	ProgramServices
Management And General	11417733	ManagementAndGeneral
Fundraising	4735797	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	300	BOY
EOY	300	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	5337194	BOY
EOY	6579091	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	4349645	BOY
EOY	5459559	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	3940777	BOY
EOY	3712320	EOY

Field	Value	IRS element (for citing)
Land Buildings Equipment Basis	65850181	LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec	8275028	LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

Field	Value	IRS element (for citing)
BOY	59126488	BOY
EOY	57575153	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	75988397	BOY
EOY	88475115	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	7274631	BOY
EOY	35506	EOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	1818474	BOY
EOY	565454	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	157835906	BOY
EOY	162402498	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	4913286	BOY
EOY	4141575	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	15358538	BOY
EOY	16505330	EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

Field	Value	IRS element (for citing)
BOY	48050000	BOY
EOY	48050000	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	25636029	BOY
EOY	35007519	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	93957853	BOY
EOY	103704424	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	63878053	BOY
EOY	58698074	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	63878053	BOY
EOY	58698074	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	157835906	BOY
EOY	162402498	EOY

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	X	InfoInScheduleOPartXI
Reconcilation Revenue Expenses	10775328	ReconcilationRevenueExpenses
Reconcilation Other Changes	-15955307	ReconcilationOtherChanges
Info In Schedule O Part XII	X	InfoInScheduleOPartXII
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	0	AccountantCompileOrReview
FS Audited	1	FSAudited
Audit Committee	1	AuditCommittee
Financial Statement Consolidated	X	FinancialStatementConsolidated
Federal Grant Audit Required	0	FederalGrantAuditRequired

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org509a2	X	PubliclySupportedOrg509a2

Gifts Grants Contrib Received509 GiftsGrantsContribReceived509

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	2928249	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	9732535	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	9749125	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	8931139	CurrentTaxYearMinus1Year
Current Tax Year	7731584	CurrentTaxYear
Total	39072632	Total

Gross Receipts From Admissions GrossReceiptsFromAdmissions

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	8421317	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	55457162	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	54860215	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	58117275	CurrentTaxYearMinus1Year
Current Tax Year	58890339	CurrentTaxYear
Total	235746308	Total

Gross Receipts From Non UBI GrossReceiptsFromNonUBI

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	89689	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	257198	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	155397	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	235462	CurrentTaxYearMinus1Year
Current Tax Year	386588	CurrentTaxYear
Total	1124334	Total

Total509 Total509

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	11439255	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	65446895	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	64764737	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	67283876	CurrentTaxYearMinus1Year
Current Tax Year	67008511	CurrentTaxYear
Total	275943274	Total

Amts Recd From Disqual Persons AmtsRecdFromDisqualPersons

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	3589400	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	11825034	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	11459125	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	10056139	CurrentTaxYearMinus1Year
Current Tax Year	7731584	CurrentTaxYear
Total	44661282	Total

Amts From Subst Contributors AmtsFromSubstContributors

Field	Value	IRS element (for citing)
Total	0	Total

Support From DQ Ps Etc SupportFromDQPsEtc

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	3589400	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	11825034	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	11459125	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	10056139	CurrentTaxYearMinus1Year
Current Tax Year	7731584	CurrentTaxYear
Total	44661282	Total

Field	Value	IRS element (for citing)
Public Support Total509	231281992	PublicSupportTotal509

Gross Investment Income509 GrossInvestmentIncome509

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	700422	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	2234994	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	1248387	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	848971	CurrentTaxYearMinus1Year
Current Tax Year	3354163	CurrentTaxYear
Total	8386937	Total

Post1975 UBTI Post1975UBTI

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	1418830	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	1237990	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	1445377	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	2794100	CurrentTaxYearMinus1Year
Current Tax Year	1677713	CurrentTaxYear
Total	8574010	Total

Investment Income And UBTI InvestmentIncomeAndUBTI

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	2119252	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	3472984	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	2693764	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	3643071	CurrentTaxYearMinus1Year
Current Tax Year	5031876	CurrentTaxYear
Total	16960947	Total

Other Income509 OtherIncome509

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	661354	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	2444918	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	2303656	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	2884051	CurrentTaxYearMinus1Year
Current Tax Year	2832350	CurrentTaxYear
Total	11126329	Total

Total Support Total TotalSupportTotal

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	14219861	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	71364797	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	69762157	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	73810998	CurrentTaxYearMinus1Year
Current Tax Year	74872737	CurrentTaxYear
Total	304030550	Total

Field	Value	IRS element (for citing)
Public Support Percentage509	0.76070	PublicSupportPercentage509
Prior Year Support Percentage	0.73680	PriorYearSupportPercentage
Investment Income Percentage	0.05580	InvestmentIncomePercentage
Prior Yr Invest Income Percentage	0.05960	PriorYrInvestIncomePercentage
Thirty Three Percnt Tests CY509	X	ThirtyThreePercntTestsCY509
General Explanation	SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: CHANGE IN FISCAL YEAR REPORTING: ASCO'S 2007 REPORTED FIGURES REPRESENT THE FINANCIAL TRANSACTIONS FROM ASCO'S SHORT-YEAR PERIOD OF SEPTEMBER 1 - DECEMBER 31, 2007. THIS SHORT-YEAR REPRESENTS A TRANSITIONAL REPORTING PERIOD FOR ASCO FROM A FISCAL YEAR END OF AUGUST 31ST TO A CALENDAR FISCAL YEAR.	GeneralExplanation

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Total Direct Lobbying TotalDirectLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	148941	FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	148941	FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	66178350	FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	66327291	FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	1000000	FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	250000	FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	1000000	CurrentYearMinus3
Current Year Minus2	1000000	CurrentYearMinus2
Current Year Minus1	1000000	CurrentYearMinus1
Current Year	1000000	CurrentYear
Total	4000000	Total

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

Field	Value	IRS element (for citing)
Current Year Minus3	181000	CurrentYearMinus3
Current Year Minus2	152632	CurrentYearMinus2
Current Year Minus1	148210	CurrentYearMinus1
Current Year	148941	CurrentYear
Total	630783	Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	250000	CurrentYearMinus3
Current Year Minus2	250000	CurrentYearMinus2
Current Year Minus1	250000	CurrentYearMinus1
Current Year	250000	CurrentYear
Total	1000000	Total

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

Field	Value	IRS element (for citing)
Current Year Minus2	214	CurrentYearMinus2
Total	214	Total

Schedule D IRS990ScheduleD

Current Year Minus2 Years CurrentYearMinus2Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	15916	BeginningOfYearBalance
Grants Or Scholarships	15916	GrantsOrScholarships

Land Land

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	7342677	OtherCostOrOtherBasis
Book Value	7342677	BookValue

Buildings Buildings

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	47946496	OtherCostOrOtherBasis
Depreciation	4188204	Depreciation
Book Value	43758292	BookValue

Equipment Equipment

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	10561008	OtherCostOrOtherBasis
Depreciation	4086824	Depreciation
Book Value	6474184	BookValue

Field	Value	IRS element (for citing)
Total Of Book Value Land Buildings	57575153	TotalOfBookValueLandBuildings

Other Liabilities OtherLiabilities (2 entries)

DescriptionDescription	AmountAmount
LIABILITY UNDER INTEREST RATE SWAP AGREEMENT	$19,057,519
TAXABLE BOND PAYABLE	$15,950,000

Field	Value	IRS element (for citing)
Total Of Amounts	35007519	TotalOfAmounts
Total Revenue	83144157	TotalRevenue
Total Expenses	72368829	TotalExpenses
Excess Or Deficit For Year	10775328	ExcessOrDeficitForYear
Net Unrealized GL On Investments	-5427154	NetUnrealizedGLOnInvestments
Other	-$10,528,153	OtherAmount
Total Adjustments	-15955307	TotalAdjustments
Excess Or Deficit Per FS	-5179979	ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt	84608011	TotRevenueEtcAuditedFinclStmt
Other Revenues	1463854	OtherRevenues
Revenue Not Rptd F990	1463854	RevenueNotRptdF990
Revenue Subtotal	83144157	RevenueSubtotal
Revenue Not Rptd On Fin Stmt	0	RevenueNotRptdOnFinStmt
Total Revenue Per Form990	83144157	TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt	73832683	TotExpensesEtcAuditedFinclStmt
Other Expenses Included	1463854	OtherExpensesIncluded
Expenses Not Rptd F990	1463854	ExpensesNotRptdF990
Expenses Subtotal	72368829	ExpensesSubtotal
Expenses Not Rptd On Fin Stmt	0	ExpensesNotRptdOnFinStmt
Total Expenses Per Form990	72368829	TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:	PART X:	THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2008 THROUGH 2011 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.
PART XI, LINE 8 - OTHER ADJUSTMENTS:		LOSS ON VALUE OF INTEREST RATE SWAP -10,528,153.
PART XII, LINE 2D - OTHER ADJUSTMENTS:		RENTAL EXPENSE TO PART VIII 1,463,854.
PART XIII, LINE 2D - OTHER ADJUSTMENTS:		RENTAL EXPENSE TO PART VIII 1,463,854.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	1	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (9 entries)

RegionRegion	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
NORTH AMERICA	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	3320
CENTRAL AMERICA AND THE CARIBBEAN	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	12647
EAST ASIA AND THE PACIFIC	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	40294
RUSSIA AND NEWLY INDEPENDENT STATES	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	25115
EUROPE	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	107371
SOUTH AMERICA	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	56264
SUB-SAHARAN AFRICA	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	38628
MIDDLE EAST & NORTH AFRICA	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	24496
SOUTH ASIA	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	43707

Field	Value	IRS element (for citing)
Subtotal Number Of Offices	0	SubtotalNumberOfOffices
Subtotal Number Of Employees	0	SubtotalNumberOfEmployees
Cont Number Of Offices	0	ContNumberOfOffices
Cont Number Of Employees	0	ContNumberOfEmployees
Total Number Of Offices	0	TotalNumberOfOffices
Total Number Of Employees	0	TotalNumberOfEmployees
Subtotal Amount Spent	308135	SubtotalAmountSpent
Cont Amount Spent	43707	ContAmountSpent
Total Amount Spent	351842	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (2 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant
EUROPE	CONTRIBUTION TO SUPPORT PROGRAMS ON INTERNATIONAL CANCER CONTROL	85180
EUROPE	CONTRIBUTION TO SUPPORT PROGRAMS ADDRESSING CANCER IN EUROPE	15150

Field	Value	IRS element (for citing)
Total Number Of501c3 Orgs	0	TotalNumberOf501c3Orgs
Total Number Of Other Orgs	2	TotalNumberOfOtherOrgs

Grants To Ind Outside US GrantsToIndOutsideUS (7 entries)

Type Of AssistanceTypeOfAssistance	RegionRegion	Number Of RecipientsNumberOfRecipients	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement	Amount Of Non Cash AssistanceAmountOfNonCashAssistance	Description Of Non Cash AssistanceDescriptionOfNonCashAssistance	Method Of ValuationMethodOfValuation
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	NORTH AMERICA	1	1100	CHECK	2220	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	SOUTH ASIA	7	7700	CHECK	32334	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	EAST ASIA AND THE PACIFIC	5	5500	CHECK	14364	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	RUSSIA AND NEWLY INDEPENDENTS STATES	2	2200	CHECK	6402	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	MIDDLE EAST & AFRICA	3	3300	CHECK	7897	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	SOUTH AMERICA	3	3300	CHECK	9485	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	SUB-SAHARAN AFRICA	1	1100	CHECK	8827	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	0	TransferToForeignCorp
Interest In Foreign Trust	0	InterestInForeignTrust
Own Foreign Corp	0	OwnForeignCorp
Passive Foreign Invest Co	0	PassiveForeignInvestCo
Foreign Partnership	0	ForeignPartnership
Boycott Countries	0	BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

Field	Value	IRS element (for citing)
Identifier	PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:	Identifier
Explanation	SCHEDULE F, PART I, LINE 2: INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA) - THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDS PROVIDE SUPPORT FOR EARLY-CAREER ONCOLOGISTS IN DEVELOPING COUNTRIES TO LEARN ABOUT ONCOLOGY CARE AND RESEARCH BY ESTABLISHING STRONG RELATIONSHIPS WITH LEADING ASCO ONCOLOGISTS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT. RECIPIENTS LEARN ABOUT QUALITY CANCER CARE AND RESEARCH BY ATTENDING IN THE ASCO ANNUAL MEETING AND VISITING THEIR MENTOR'S CANCER CENTER IN THE UNITED STATES AND CANADA. RECIPIENTS ARE EXPECTED TO SHARE THE KNOWLEDGE AND TRAINING THEY RECEIVE THROUGH THE PROGRAM WITH COLLEAGUES IN THEIR HOME COUNTRIES ONCE THEY RETURN. IDEAS ARE PROVIDED TO RECIPIENTS BASED ON MERIT THROUGH A PEER REVIEW PROCESS OF REVIEW USING ESTABLISHED ELIGIBILITY CRITERIA. IDEA RECIPIENTS ARE REQUIRED TO AGREE TO TERMS AND CONDITIONS APPLICABLE TO THE IDEA, ARE REQUIRED TO COMMUNICATE WITH THEIR MENTORS, TO ATTEND ALL IDEA-RELATED EVENTS, AND TO SUBMIT EVALUATIONS AFTER THE ANNUAL MEETING AND MENTOR SITE VISIT AND A SUBMIT ONE-YEAR REPORTS.	Explanation

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Agreement Ref Fundraising	1	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation

Name Of Organization NameOfOrganization

Field	Value	IRS element (for citing)
Business Name Line1	GRAHAM PELTON CONSULTING	BusinessNameLine1

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	39 BEECHWOOD RD	AddressLine1
City	SUMMIT	City
State	NJ	State
ZIP Code	07901	ZIPCode

Field	Value	IRS element (for citing)
Activity	FUNDRAISING CONSULTANT	Activity
Fundraiser Control Of Funds	0	FundraiserControlOfFunds
Gross Receipts	0	GrossReceipts
Amount Retained By Contractor	520215	AmountRetainedByContractor
Net To Organization	-520215	NetToOrganization

Field	Value	IRS element (for citing)
Total Retained By Contractors	520215	TotalRetainedByContractors
Total Net To Organization	-520215	TotalNetToOrganization
Licensed States	VA	LicensedStates
Licensed States	NY	LicensedStates

Form990 Schedule G Part IV Form990ScheduleGPartIV

Field	Value	IRS element (for citing)
Identifier	EXPLANATION OF FUNDRAISING PAYMENTS	Identifier
Return Reference	SCHEDULE G, PART I, LINE 2B, COLUMN (V)	ReturnReference
Explanation	PAYMENTS TO GRAHAM PELTON WERE FOR FUNDRAISING SERVICES FOR ASCO'S 501(C)(3) RELATED ORGANIZATION, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY TO DETERMINE FUNDRAISING BEST PRACTICES - NO REVENUE WAS RECEIVED.	Explanation

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	1	RecordsMaintained

Recipient Table RecipientTable (16 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Purpose Of GrantPurposeOfGrant
HEALTH VOLUNTEERS OVERSEAS
1900 L STREET NW 310	WASHINGTON	DC	20036	521485477	501(C)(3)	6000	CONTRIBUTION
FRIENDS OF CANCER RESEARCH
3299 K ST NW	WASHINGTON	DC	20007	521983273	501(C)(3)	20000	CONTRIBUTION
AMERICAN COLLEGE OF SURGEONS
633 NORTH ST CLAIR	CHICAGO	IL	60611	362192800	501(C)(3)	25000	CONTRIBUTION
NATIONAL ACADEMY OF SCIENCES
2101 CONSTITUTION AVENUE NW	WASHINGTON	DC	20418	530196932	501(C)(3)	53000	CONTRIBUTION
BROOKINGS INSTITUTION
1775 MASSACHUSETTS AVE	WASHINGTON	DC	20036	530196577	501(C)(3)	10000	CONTRIBUTION
WASHINGTON HOSPITAL CENTER
110 IRVING ST NW	WASHINGTON	DC	20010	521272129	501(C)(3)	42652	CONTRIBUTION
KOMEN NAT'L RACE FOR THE CURE
1911 N FORT MYER DR 112	ARLINGTON	VA	22209	751835298	501(C)(3)	30000	CONTRIBUTION
CONQUER CANCER FOUNDATION
2318 MILL ROAD 800	ALEXANDRIA	VA	22314	311667995	501(C)(3)	871450	CONTRIBUTION
MEMORIAL SLOAN KETTERING CANCER CENTER
PO BOX 026338	NEW YORK	NY	10087	131924236	501(C)(3)	44274	CONTRIBUTION
INDIANA UNIVERSITY
620 UNION DRIVE	INDIANAPOLIS	IN	46202	356001673	501(C)(3)	85231	CONTRIBUTION
STANFORD UNIVERSITY
1000 WELCH ROAD 301	STANFORD	CA	94301	941156365	501(C)(3)	143294	CONTRIBUTION
PREVENT CANCER FOUNDATION
1600 DUKE ST 500	ALEXANDRIA	VA	22314	521429544	501(C)(3)	45000	CONTRIBUTION
CANCERCARE
275 7TH AVE	NEW YORK	NY	10001	131825919	501(C)(3)	5000	CONTRIBUTION
BREAST CANCER RESEARCH FOUNDATION
654 MADISON AVE 1209	NEW YORK	NY	10021	133727250	501(C)(3)	15000	CONTRIBUTION
NATIONAL COALITION FOR CANCER SURVIVORSHIP
1010 WAYNE AVE 770	SILVER SPRING	MD	20910	850357897	501(C)(3)	25000	CONTRIBUTION
DUKE CANCER CENTER
2424 ERWIN RD SUITE 601	DURHAM	NC	27705	560532129	501(C)(3)	50000	CONTRIBUTION

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	16	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	0	TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	PROCEDURE FOR MONITORING GRANTS IN THE U.S.:	Identifier
Return Reference	PART I, LINE 2:	ReturnReference
Explanation	SCHEDULE I, PART I, LINE 2: IN PRIOR YEARS, ASCO GRANTED SEVERAL SPECIAL AWARDS INTENDED TO RECOGNIZE AND ENCOURAGE INDIVIDUALS OR ORGANIZATIONS WHOSE COMMITMENT TO FURTHERING THE PROGRESS AGAINST CANCER HAS LED TO TREMENDOUS CONTRIBUTIONS TO THE FIELD OF CLINICAL ONCOLOGY, CANCER PATIENTS, AND ASCO. IN 2011, ASCO TRANSFERRED THESE AWARD PROGRAMS TO ITS RELATED 501(C)(3) ORGANIZATION, THE 'CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY.'	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Housing Allowance Or Residence	X	HousingAllowanceOrResidence
Written Policy Re T And E Expenses	1	WrittenPolicyReTAndEExpenses
Substantiation Required	1	SubstantiationRequired
Compensation Committee	X	CompensationCommittee
Independent Consultant	X	IndependentConsultant
Form990 Of Other Organizations	X	Form990OfOtherOrganizations
Written Employment Contract	X	WrittenEmploymentContract
Compensation Survey	X	CompensationSurvey
Board Or Committee Approval	X	BoardOrCommitteeApproval
Severance Payment	0	SeverancePayment
Supplemental Nonqual Retire Plan	0	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	0	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	0	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	0	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	0	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	0	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	1	AnyNonFixedPayments
Initial Contract Exception	1	InitialContractException
Rebuttable Presumption Procedure	1	RebuttablePresumptionProcedure

Form990 Schedule J Part II Form990ScheduleJPartII (14 entries)

Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
ALLEN LICHTER MD
666323	0	67571	0	15000	0	18375	0	1787	0	769056	0	0	0
PAUL AINES CPA
282362	0	5000	0	0	0	16442	0	16509	0	320313	0	0	0
DINA MICHELS ESQ
468167	0	0	0	0	0	18375	0	15692	0	502234	0	0	0
NANCY DALY MSMPH
199675	0	10849	0	0	0	11722	0	12209	0	234455	0	0	0
JEAN COLVARD
200814	0	4000	0	0	0	12346	0	6270	0	223430	0	0	0
DEBORAH KAMIN RNPHD
279056	0	6000	0	0	0	13096	0	15692	0	313844	0	0	0
BERNIE KHOO
327928	0	3000	0	0	0	18375	0	16509	0	365812	0	0	0
CARA MOLINARI
173782	0	5000	0	0	0	6092	0	6159	0	191033	0	0	0
THERESA VAN SCHAIK
174248	0	5000	0	0	0	10096	0	12129	0	201473	0	0	0
SUZANNE BRACH
190974	0	4000	0	0	0	11308	0	12196	0	218478	0	0	0
KRISTIN LUDWIG
216216	0	5000	0	0	0	12462	0	1228	0	234906	0	0	0
KAY NOLL
187726	0	4000	0	0	0	10731	0	6227	0	208684	0	0	0
DOUGLAS PYLE
176714	0	4000	0	0	0	10385	0	15628	0	206727	0	0	0
ROBERT HAUSER PHARMD PHD
136642	0	30000	0	0	0	0	0	4410	0	171052	0	0	0

Form990 Schedule J Part III Form990ScheduleJPartIII (3 entries)

Return ReferenceReturnReference	ExplanationExplanation
PART I, LINE 1A	A HOUSING ALLOWANCE IS PROVIDED TO THE CEO, WHICH IS CONSIDERED PART OF THE CEO'S COMPENSATION AND ADDRESSED IN THE CEO'S WRITTEN EMPLOYMENT CONTRACT. THE HOUSING ALLOWANCE IS TREATED AS TAXABLE COMPENSATION.
PART I, LINE 7	PERFORMANCE-BASED BONUS PAYMENTS CAN BE MADE TO SOME EMPLOYEES LISTED ON SCHEDULE J AND INCLUDED AS PART OF THE TOTAL COMPENSATION. THE BONUS PAYMENTS ARE NOT ON A FIXED BASIS BUT RATHER ARE BASED ON PERFORMANCE AND DETERMINED BY THE CEO WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE.
PART I, LINE 8	CERTAIN AMOUNTS PAID OR ACCRUED TO THE CEO AND THE VP/GC WERE PURSUANT TO A CONTRACT THAT WAS SUBJECT TO THE INITIAL CONTRACT EXCEPTION DESCRIBED IN TREAS. REGS. SECTION 53.4958-4(A)(3).

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	INDUSTRIAL DEVELOPMENT AUTHORITY CITY OF ALEXANDRIA	BusinessNameLine1

Field	Value	IRS element (for citing)
Issuer EIN	521381432	IssuerEIN
CUSIP Number	01530LAD2	CUSIPNumber
Date Issued	2008-04-23	DateIssued
Issue Price	48050000	IssuePrice
Description Of Purpose	BUY/BLDOUT 5 FLS HQ BLDG	DescriptionOfPurpose
Defeased	0	Defeased
On Behalf Of Issuer	0	OnBehalfOfIssuer
Pool Financing	0	PoolFinancing

Form990 Schedule K Part II Form990ScheduleKPartII

Field	Value	IRS element (for citing)
Total Proceeds	48050000	TotalProceeds
Issuance Costs From Proceeds	79362	IssuanceCostsFromProceeds
Capital Expenditures	47970638	CapitalExpenditures
Year Of Subst Completion	2008	YearOfSubstCompletion
Current Refunding	0	CurrentRefunding
Advance Refunding	0	AdvanceRefunding
Final Allocation Made	1	FinalAllocationMade
Adequate Books And Recds Maintaind	1	AdequateBooksAndRecdsMaintaind

Form990 Schedule K Part III Form990ScheduleKPartIII

Field	Value	IRS element (for citing)
Owning Bond Financed Property	0	OwningBondFinancedProperty
Any Lease Arrangements	0	AnyLeaseArrangements
Mngment Cntrct Bond Financd Prprty	1	MngmentCntrctBondFinancdPrprty
Engage Bond Counsel Contracts	1	EngageBondCounselContracts
Any Research Agreements	0	AnyResearchAgreements
Prcntge Prvt Business Use By Others	0.00000	PrcntgePrvtBusinessUseByOthers
Percentage Of Prvt Business Re UBI	0.08300	PercentageOfPrvtBusinessReUBI
Total Private Business Use	0.08300	TotalPrivateBusinessUse
Post Issuance Compliance Procdrs	1	PostIssuanceComplianceProcdrs

Form990 Schedule K Part IV Form990ScheduleKPartIV

Field	Value	IRS element (for citing)
Form8038 T Filed	0	Form8038TFiled
Variable Rate Issue	1	VariableRateIssue
Hedge Identified In Books And Recds	1	HedgeIdentifiedInBooksAndRecds

Name Of Hedge Provider NameOfHedgeProvider

Field	Value	IRS element (for citing)
Business Name Line1	DEPFA BANK	BusinessNameLine1

Field	Value	IRS element (for citing)
Term Of Hedge	30.000000000000	TermOfHedge
Superintegrated Hedge	0	SuperintegratedHedge
Hedge Terminated	0	HedgeTerminated
Gross Proceeds Invested In GIC	0	GrossProceedsInvestedInGIC
Gross Proceeds Invested	0	GrossProceedsInvested
Exception To Rebate	0	ExceptionToRebate

Field	Value	IRS element (for citing)
Fed Tax Requirements Compliance	X	FedTaxRequirementsCompliance

Form990 Schedule K Part VI Form990ScheduleKPartVI (2 entries)

IdentifierIdentifier

ExplanationExplanation

PART III, QUESTION 6

THE PERCENTAGE OF FINANCED PROPERTY USED IN A PRIVATE BUSINESS USE AS A RESULT OF UNRELATED BUSINESS ACTIVITY IS 8.3% FOR 2011. HOWEVER, THE AVERAGE ANNUAL PERCENTAGE OF PRIVATE BUSINESS USE SINCE THE BEGINNING OF THE MEASUREMENT PERIOD IS LESS THAN 1%.

PART IV, QUESTION 3:

ASCO HAS AN INTEREST RATE SWAP AGREEMENT WITH DEPFA BANK THROUGH 2038. ASCO MAKES FIXED INTEREST PAYMENTS AT A 3.587% RATE. VARIABLE SWAP PAYMENTS, BASED ON ONE-MONTH LIBOR, RECEIVED FROM THE SWAP COUNTERPARTY ARE USED TO MAKE THE VARIABLE INTEREST PAYMENTS AS THEY COME DUE. THESE INTEREST RATE SWAP AGREEMENTS QUALIFY AS A DERIVATIVE INSTRUMENT AND ARE USED TO MITIGATE THE EFFECT OF INTEREST RATE FLUCTUATIONS.

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (13 entries)

Return ReferenceReturnReference	ExplanationExplanation	IdentifierIdentifier
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2011, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH VOTING RIGHTS: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND 14 DIRECTORS. ALL VOTING MEMBERS OF THE BOARD OF DIRECTORS ARE ELECTED BY VOTING MEMBERS OF ASCO AND HAVE THE SAME VOTING RIGHTS. THE CHIEF EXECUTIVE OFFICER (CEO) IS AN EX-OFFICIO, NON-VOTING MEMBER OF THE BOARD OF DIRECTORS. ADDITIONALLY, THE CHAIR OF THE BOARD OF CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (A NON-PROFIT, 501(C)(3) TAX EXEMPT RELATED ORGANIZATION OF ASCO) IS AN EX-OFFICIO, NON-VOTING MEMBER OF THE BOARD OF DIRECTORS OF ASCO. DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. DURING THE REPORTING YEAR, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE WERE: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND THOSE DIRECTORS SERVING THEIR FINAL YEAR OF THEIR TERM. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD OF DIRECTORS AT THE MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 1	ONE VOTING MEMBER OF ASCO'S BOARD OF DIRECTORS DOES NOT MEET THE DEFINITIONAL TEST OF AN INDEPENDENT MEMBER OF ASCO'S GOVERNING BODY: CLIFFORD HUDIS, MD IS THE TREASURER OF ASCO AND A VOTING MEMBER OF ASCO'S BOARD OF DIRECTORS. HE WAS COMPENSATED BY ASCO FOR HIS WORK AS AN EDITOR TO JOURNAL OF CLINICAL ONCOLOGY.
FORM 990, PART VI, SECTION A, LINE 4	IN 2011, VOTING ASCO MEMBERS APPROVED AMENDMENTS TO ASCO'S BYLAWS, WHICH INCLUDED: --ADDING A NEW STUDENT/NON-ONCOLOGY RESIDENT MEMBERSHIP CATEGORY. THESE MEMBERS ARE NOT ENTITLED TO HOLD OFFICE, VOTE, OR SERVE AS VOTING MEMBERS ON ASCO COMMITTEES; --CHANGING THE NAMES OF SOME MEMBERSHIP CATEGORIES; --REMOVING DETAILS FROM THE BYLAWS THAT COULD BE ADDRESSED IN OTHER POLICY DOCUMENTS (SUCH AS SPONSORSHIP OF MEMBERSHIP AND OF ABSTRACTS SUBMITTED TO ASCO MEETINGS AND REFERENCES TO SOME COMMITTEES) --ADDING THE CHAIR OF CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO'S RELATED, NONPROFIT, 501(C)(3) TAX EXEMPT ORGANIZATION) AS AN EX OFFICIO, NON-VOTING MEMBER OF THE ASCO BOARD; --PROVIDING A PROCESS TO ADDRESS WHEN AN ASCO BOARD DIRECTOR CHANGES HIS/HER "CLASS" DURING HIS/HER TERM; --EXTENDING THE TERM OF THE DESIGNATED COMMUNITY ONCOLOGIST ON THE NOMINATING COMMITTEE FROM 1 TO 3 YEARS TO BE ON PAR WITH OTHER NOMINATING COMMITTEE MEMBERS; --HAVING MEMBERS ELECT THE DESIGNATED COMMUNITY ONCOLOGIST ON THE NOMINATING COMMITTEE; --CLARIFYING THAT BOTH THE BOARD AND MEMBERS MUST APPROVE BYLAWS AMENDMENTS; --USING THE REQUIRED MEMBER QUORUM NUMBER (100) AS THE NUMBER OF MEMBERS NEEDED TO PROPOSE BYLAWS AMENDMENTS; AND --MAKING VARIOUS NOTICE REQUIREMENTS CONSISTENT WITH EACH OTHER.
FORM 990, PART VI, SECTION A, LINE 6	ASCO MEMBERS ARE ELECTED BY THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. THE CATEGORIES OF MEMBERSHIP AND SPECIFIED RIGHTS ARE AS FOLLOWS: 1. FULL MEMBERS. 1.A. FULL MEMBERS ARE EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER ARE ELIGIBLE FOR ACTIVE MEMBER STATUS. 1.B. RIGHTS OF FULL MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, AND VOTE AND HOLD OFFICE IN ASCO. 2. INTERNATIONAL CORRESPONDING MEMBERS. 2.A. INTERNATIONAL CORRESPONDING MEMBERS ARE EXPERIENCED PHYSICIANS WHO ARE ELIGIBLE TO BE FULL MEMBERS, BUT WHO RESIDE IN A DEVELOPING NATION OR A NATION WITH A LOW PER-CAPITA INCOME, AS DEFINED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. 2.B. RIGHTS OF INTERNATIONAL CORRESPONDING MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. INTERNATIONAL CORRESPONDING MEMBERS MAY NOT SERVE ON COMMITTEES OF ASCO, AND MAY NOT VOTE OR HOLD OFFICE IN ASCO. 3. ALLIED PHYSICIAN/DOCTORAL SCIENTIST MEMBERS. 3.A. ALLIED PHYSICIAN/DOCTORAL SCIENTIST MEMBERS ARE OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANK WHO ARE NOT ELIGIBLE TO BE AN FULL MEMBER AND WHO HAVE A PREDOMINANT INTEREST IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. 3.B. RIGHTS OF ALLIED PHYSICIAN/DOCTORAL SCIENTIST MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND TO SERVE ON ALL COMMITTEES OF ASCO. ACTIVE-ALLIED MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 4. AFFILIATED HEALTH PROFESSIONAL MEMBERS. 4.A. AFFILIATED HEALTH PROFESSIONAL MEMBERS ARE AFFILIATED HEALTH PROFESSIONALS IN ONCOLOGY, INCLUDING ONCOLOGY NURSES, PHYSICIAN ASSISTANTS, AND OTHER HEALTH SPECIALISTS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO THE CARE AND TREATMENT OF PATIENTS WITH NEOPLASTIC DISEASES. MEMBERSHIP IS LIMITED TO THOSE PERSONNEL WHO FUNCTION AS INTEGRAL MEMBERS OF A TEAM OF ONCOLOGISTS RESPONSIBLE FOR THE CARE OF SUCH PATIENTS OR WHO ENGAGE IN THE CONDUCT OF CLINICAL TRIALS. ELECTION TO MEMBERSHIP IS BASED ON EXPERIENCE IN AND CONTRIBUTIONS TO THE FIELD OF ONCOLOGY. ADDITIONALLY, AFFILIATED HEALTH PROFESSIONAL MEMBERS STATUS INCLUDES INDIVIDUALS WHO HOLD LEADERSHIP POSITIONS OR HAVE TAKEN A DISTINGUISHED LEADERSHIP ROLE IN A NATIONALLY OR INTERNATIONALLY RECOGNIZED NOT-FOR-PROFIT, TAX-EXEMPT ORGANIZATION DEDICATED TO CANCER PATIENT ADVOCACY OR SURVIVORSHIP. 4.B. RIGHTS OF AFFILIATED HEALTH PROFESSIONAL MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS AND SERVE ON ALL COMMITTEES OF ASCO. AFFILIATED HEALTH PROFESSIONAL MEMBERS MAY NOT VOTE OR HOLD OFFICE IN ASCO. 5. EMERITUS MEMBERS. 5.A. EMERITUS MEMBERS ARE FULL, ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING AND AFFILIATED HEALTH PROFESSIONAL MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 65, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. 5.B. RIGHTS OF EMERITUS MEMBERS INCLUDE BEING EXEMPT FROM MEMBERSHIP DUES. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE FULL MEMBERS RETAIN ALL RIGHTS AND PRIVILEGES OF FULL MEMBER STATUS, EXCEPT THE HOLDING OF OFFICE. EMERITUS MEMBERS WHO WERE PREVIOUSLY ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING OR AFFILIATED HEALTH PROFESSIONAL MEMBERS RETAIN ALL THE RIGHTS AND PRIVILEGES OF ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING OR AFFILIATED HEALTH PROFESSIONAL MEMBER STATUS RESPECTIVELY. 6. HONORARY MEMBERS. 6.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. 6.B. RIGHTS OF HONORARY MEMBERS INCLUDE HAVING ALL PRIVILEGES OF FULL MEMBERS, EXCEPT THEY MAY NOT HOLD OFFICE AND ARE EXEMPT FROM PAYING MEMBERSHIP DUES. 7. MEMBER IN TRAINING MEMBERS. 7.A. MEMBER IN TRAINING MEMBERS ARE HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL WHO ARE PARTICIPATING IN A SUBSPECIALTY TRAINING PROGRAM IN ONCOLOGY OR ANOTHER FIELD THAT WOULD LEAD TO ELIGIBILITY FOR FULL OR ALLIED PHYSICIAN/DOCTORAL SCIENTIST MEMBERSHIP. 7.B. RIGHTS OF MEMBER IN TRAINING MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. MEMBER IN TRAINING MEMBERS MAY NOT HOLD OFFICE OR VOTE, EXCEPT THAT THEY MAY SERVE AS VOTING MEMBERS OF COMMITTEES OF ASCO. 8. STUDENT/NON-ONCOLOGY RESIDENT MEMBERS. 8.A. STUDENT/NON-ONCOLOGY RESIDENT MEMBERS ARE MEDICAL RESIDENTS, MEDICAL STUDENTS, GRADUATE STUDENTS, AND UNDERGRADUATE STUDENTS WHO ARE ENROLLED IN A BIOMEDICAL NURSING OR ALLIED HEALTH PROGRAM, AND WHO HAVE A PREDOMINANT INTEREST IN THE BIOLOGY, DIAGNOSIS, PREVENTION, OR TREATMENT OF HUMAN CANCER. 8.B. RIGHTS OF STUDENT/NON-ONCOLOGY RESIDENT MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS. STUDENT/NON-ONCOLOGY RESIDENT MEMBERS ARE NOT ELIGIBLE TO VOTE OR HOLD OFFICE OR TO SERVE AS VOTING MEMBERS OF COMMITTEES OF ASCO.
FORM 990, PART VI, SECTION A, LINE 7A	VOTING MEMBERS OF ASCO ELECT ALL 18 VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS: THE PRESIDENT, PRESIDENT-ELECT, PAST-PRESIDENT, TREASURER, AND 14 DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE ASCO FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD BEFORE IT WAS FILED. THE ASCO FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE VICE PRESIDENT AND GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. AN ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE CEO OF ASCO'S NON-PROFIT, 501(C)(3) TAX-EXEMPT RELATED ORGANIZATION, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION); THE PRESIDENT OF INSTITUTE OF CLINICAL EXCELLENCE, LLC (D/B/A QOPI CERTIFICATION PROGRAM); AND THE PRESIDENT OF ASCO LEASING LLC. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE BOARD COMPENSATION COMMITTEE. IN 2010, THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT HAD COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE CEO WAS REASONABLE. THE INDEPENDENT COMPENSATION CONSULTANT'S 2010 OPINION ON THE CEO'S COMPENSATION CONTEMPLATED MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. IN 2011, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND REVIEWED AGAIN THE 2010 OPINION OF ITS INDEPENDENT COMPENSATION CONSULTANT THAT THE CEO'S COMPENSATION WAS REASONABLE, INCLUDING THE CONSULTANT'S OPINION ON THE MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. COMPENSATION OF CERTAIN OFFICERS AND KEY EMPLOYEES OF ASCO VICE PRESIDENT/GENERAL COUNSEL: THE COMPENSATION OF THE VICE PRESIDENT/GENERAL COUNSEL (VP/GC) WAS CONSIDERED AND APPROVED BY THE BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. IN 2010, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT HAD COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE VP/GC WAS REASONABLE. IN 2011, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND THE INDEPENDENT COMPENSATION CONSULTANT, WHICH UPDATED ITS 2010 OPINION AND FOUND AGAIN THAT THE VP/GC'S PROPOSED COMPENSATION, WAS REASONABLE. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE VP/GC AND ASCO ADDRESSES COMPENSATION OF THE VP/GC. CHIEF FINANCIAL OFFICER (CFO). THE COMPENSATION OF THE CHIEF FINANCIAL OFFICER (CFO) WAS CONSIDERED AND APPROVED BY THE BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. IN 2010, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CFO WAS REASONABLE. THE INDEPENDENT COMPENSATION CONSULTANT'S 2010 OPINION ON THE COMPENSATION OF THE CFO CONTEMPLATED MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. IN 2011, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND REVIEWED AGAIN THE 2010 OPINION OF ITS INDEPENDENT COMPENSATION CONSULTANT THAT THE CFO'S COMPENSATION WAS REASONABLE, INCLUDING THE CONSULTANT'S OPINION ON THE MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. EXECUTIVE DIRECTOR OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF) (FORMERLY KNOWN AS THE ASCO CANCER FOUNDATION). THE EXECUTIVE DIRECTOR OF CCF IS AN EMPLOYEE OF ASCO. THE ASCO BOARD COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. IN 2010, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF WAS REASONABLE. THE INDEPENDENT COMPENSATION CONSULTANT'S 2010 OPINION ON THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF CONTEMPLATED MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. . IN 2011, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND REVIEWED AGAIN THE 2010 OPINION OF ITS INDEPENDENT COMPENSATION CONSULTANT THAT THE EXECUTIVE DIRECTOR OF CCF'S COMPENSATION WAS REASONABLE, INCLUDING THE CONSULTANT'S OPINION ON THE MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY. THE BOARD COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. IN 2010, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY WAS REASONABLE. THE INDEPENDENT COMPENSATION CONSULTANT'S 2010 OPINION ON THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY CONTEMPLATED MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD. IN 2011, THE BOARD COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND REVIEWED AGAIN THE 2010 OPINION OF ITS INDEPENDENT COMPENSATION CONSULTANT THAT THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY'S COMPENSATION WAS REASONABLE, INCLUDING THE CONSULTANT'S OPINION ON THE MARKET-BASED COMPENSATION INCREASES IN YEARS GOING FORWARD.
FORM 990, PART VI, SECTION C, LINE 19	ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE, WAS PUBLISHED IN THE JANUARY 20, 2006 EDITION OF JOURNAL OF CLINICAL ONCOLOGY (THE EDITION IS AVAILABLE TO THE PUBLIC FOR FREE), AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S ANNUAL REPORT IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST.
FORM 990, PART VI, SECTION A, LINE 7B:	NO DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO APPROVAL BY MEMBERS, STOCKHOLDERS, OR OTHER PERSONS. HOWEVER, THE BYLAWS MAY ONLY BE AMENDED AND DISSOLUTION OF THE CORPORATION MAY ONLY BE APPROVED WITH THE APPROVAL OF BOTH THE BOARD OF DIRECTORS AND VOTING MEMBERS OF ASCO. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 10B:	ALTHOUGH ASCO HAS STATE AND REGIONAL AFFILIATES THROUGH ITS STATE AND REGIONAL AFFILIATE PROGRAM, ASCO DOES NOT HAVE THE LEGAL AUTHORITY TO EXERCISE SUPERVISION AND CONTROL OVER THEM AND EACH AFFILIATE IS A SEPARATELY INCORPORATED LEGAL ENTITY THAT IS RESPONSIBLE FOR ITS OWN FISCAL MANAGEMENT. AFFILIATES MAY NOT ACT ON BEHALF OF ASCO AND ARE PROHIBITED FROM ANY ACTION THAT MIGHT IMPLY AN AGENCY RELATIONSHIP. AFFILIATES MAY NOT BIND ASCO TO ANY CONTRACT WITH A THIRD PARTY. ASCO'S STATE AND REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ASSIST STATE AND REGIONAL SOCIETIES IN ADDRESSING THE PRACTICAL ISSUES FACING PHYSICIANS WHO CARE FOR PEOPLE WITH CANCER AND TO FACILITATE AND ENCOURAGE INVOLVEMENT IN ASCO'S PUBLIC POLICY INITIATIVES. EACH AFFILIATE HAS A VOTING REPRESENTATIVE ON THE ASCO CLINICAL PRACTICE COMMITTEE (CPC), WHICH IS INTENDED TO ADDRESS THE PRACTICE OF ONCOLOGY, WITH A PARTICULAR FOCUS ON REIMBURSEMENT FOR, ACCESS TO, AND QUALITY OF MEDICAL ONCOLOGY SERVICES. THROUGH PARTICIPATION IN THE CPC, AFFILIATES HAVE A ROLE IN THE DEVELOPMENT OF PUBLIC POLICY POSITIONS AT THE NATIONAL LEVEL AND ALSO RECEIVES INPUT REGARDING STATE AND REGIONAL ISSUES AFFECTING ONCOLOGY. STATE AND REGIONAL SOCIETIES INTERESTED IN BEING AFFILIATES MUST SUBMIT AN APPLICATION TO ASCO THAT, AMONG OTHER THINGS, REQUIRES THEM TO DEMONSTRATE THAT THEY ARE VALIDLY INCORPORATED UNDER STATE LAW, HAVE IN PLACE GOVERNANCE PRACTICES AND PROCEDURES (BYLAWS, OFFICERS, DIRECTORS, ELECTIONS, MEETINGS, AND RESPONSIBLE FISCAL MANAGEMENT), AND HAVE PHYSICIAN MEMBERSHIP REQUIREMENTS THAT ARE CONSISTENT WITH ASCO'S STANDARDS. ASCO PROVIDES STATE AFFILIATES WITH A VARIETY OF ASSISTANCE, INCLUDING ASCO POLICY ANALYSES, ACCESS TO ASCO STAFF ON MATTERS OF INTEREST TO STATE AFFILIATES, AND ASSISTANCE WITH MEDIA AND OUTREACH.
FORM 990, PART XI, LINE 5:	NET UNREALIZED LOSSES ON INVESTMENTS: -5,427,154. LOSS ON VALUE OF INTEREST RATE SWAP -10,528,153. TOTAL TO FORM 990, PART XI, LINE 5: -15,955,307.	CHANGES IN NET ASSETS OR FUND BALANCES:
FORM 990, PART XII, LINE 2C	COMMITTEE OVERSIGHT OF THE AUDIT--ASCO HAS A COMMITTEE THAT ASSUMES RESPONSIBILITY FOR OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF AN INDEPENDENT AUDIT FIRM. THIS PROCESS HAS NOT CHANGED FROM THE PREVIOUS YEAR.

Schedule R IRS990ScheduleR

Form990 Schedule R Part I Form990ScheduleRPartI (2 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EINEIN	Primary ActivitiesPrimaryActivities	Legal Domicile StateLegalDomicileState	Total IncomeTotalIncome	EOY AssetsEOYAssets	Business Name Line1DirectControllingEntityName/BusinessNameLine1
INSTITUTE OF CLINICAL EXCELLENCE LLC
2318 MILL ROAD	ALEXANDRIA	VA	22314	271629211	QOPI CERTIFICATION PROGAM	VA	85022	213980	AMERICAN SOCIETY OF CLINICAL ONCOLOGY
ASCO LEASING LLC
2318 MILL ROAD	ALEXANDRIA	VA	22314	273378225	RENTAL OF 5TH FLOOR	VA	946187	190030	AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Form990 Schedule R Part II Form990ScheduleRPartII

Name Of Disregarded Entity NameOfDisregardedEntity

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF ASCO (CCF)	BusinessNameLine1

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
EIN	311667995	EIN
Primary Activities	DEDICATED TO CONQUERING CANCER WORLDWIDE BY FUNDING RESEARCH	PrimaryActivities
Legal Domicile State	VA	LegalDomicileState
Exempt Code Section	501 (C)(3)	ExemptCodeSection
Public Charity Status	509 (A)(1)	PublicCharityStatus
Controlled Org	1	ControlledOrg

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	1	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	1	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	1	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	1	LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org	0	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	0	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	0	ExchangeOfAssets
Rental Of Facilities To Other Orgs	1	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	0	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	0	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	1	PerformOfServicesByOtherOrgs
Sharing Of Facilities	0	SharingOfFacilities
Sharing Of Paid Employees	1	SharingOfPaidEmployees
Reimbursement Paid To Other Org	1	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	1	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	0	OtherTransferToOtherOrg
Other Transfer From Other Org	0	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (9 entries)

Transaction TypeTransactionType	Amount InvolvedAmountInvolved	Method Of Amt DeterminationMethodOfAmtDetermination
CCF
A	231180	FMV
CCF
B	871450	FMV
CCF
C	7731584	FMV
CCF
E	64000000	FMV
CCF
I	231180	FMV
CCF
L	4676846	FMV
CCF
N	2560538	FMV
CCF
O	2327368	V
CCF
P	5425123	FMV